The Advance Project - Advancing Sleep Timing to Improve Depression, a Randomised Clinical Trial.

Sponsor
Mental Health Centre Copenhagen (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06097221
Collaborator
(none)
150
1
2
32
4.7

Study Details

Study Description

Brief Summary

150 patients with moderate to severe depression, recently discharged from a psychiatric ward and now recieving treatment at an outpatient unit at Mental Health Center Copenhagen, will be randomised in to two groups. A treatment ad usual (TAU) group and an Advance-group. The Advance-group will receive a psychotherapeutic intervention focusing on advancing sleep timing to improve depression.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: CRT-Advance
  • Behavioral: Treatment as usual
N/A

Detailed Description

Objective Patients treated at outpatient psychiatric services for major depression improves slowly from their depression despite use of psychopharmacological, psychological, and supportive methods. This is in many cases due to severe sleep disturbances as part of their current depressive episode. Typically, these patients have difficulties keeping their habitual sleep-wake cycle, that drifts to later in the evening and morning. Thus, patients who, before being depressed, sleeps around 11 PM and wake up around 7 AM, often drift to a later sleep schedule at around 1 AM and a wake-up time at 9 AM or even later during their depressive period (Lauritsen et al., 2017). The reason for the drift of the sleep schedule is mainly caused by reduced signals to the circadian system from daylight, social input, dieting and exercise. This reduced input is partly a result of the changed behavior of patients due to their depressive symptoms making them less structured, less socially active, less physically active, eating erratically, and staying more indoors thereby receiving less daylight (Czeisler and Gooley, 2007, Tahara and Shibata, 2013, Yamanaka et al., 2015, Grandin et al., 2006). Another reason for the sleep drift is the presence of diurnal variation of depressive symptoms with morning worsening and evening improvement tempting patients to stay up later because of the better evening mood (Germain and Kupfer, 2008, Gordijn et al., 1994). The sleep drift makes patients out of synchrony with societal and workplace rhythms, and we have clinical and research evidence for mood worsening associated with sleep drift(Lauritsen et al., 2017) and of improvement of depression when patients correct their sleep drift (Voderholzer et al., 2003).

The physiological background behind why late sleep worsens and maintain depression is thought to be caused by a sleep induced inhibition of the raphe nuclei in the brain stem downregulating the serotonergic activity in the forebrain in the late phase of the sleep period (Jacobs and Azmitia, 1992, Baldassarri et al., 2020).

The association between depression and sleep/sleep timing is well established from the bulk of literature on sleep deprivation (Martiny et al., 2012), and sleep phase advance (Voderholzer et al., 2003, Kurczewska et al., 2019). Regulation of sleep disturbances thus has a great potential as a specific new treatment target.

Our recent study showed that a newly developed psychoeducation method, Circadian Reinforcement Therapy (CRT) could prevent sleep drift and improve mood (Aggestrup et al., 2023, Dunker Svendsen et al., 2019) in patients discharged from inpatient wards. The standard psychoeducation manuals used at psychiatric services do not focus adequately on the relation between signals to the circadian system, sleep timing, and mood (Wirz-Justice and Benedetti, 2020). The principle in the CRT is based on scientific findings that sleep timing and thus mood is for a large part a result of how the actual day is spend - what signals is reaching the circadian system (Volf et al., 2020). The influence of light during the day is termed Prior Light History and has been documented to influence sleep, circadian rhythms, and melatonin secretion/suppression (Münch et al., 2016, Hébert et al., 2002, Gooley et al., 2011, Chang et al., 2013). The main time signals to the circadian system (zeitgebers) are light (electrical or daylight), social activity, exercise, and diet. The CRT method aimed to strengthen all these time signals and normalize the sleep timing leading to improvement of depression.

The objective of this project is to investigate whether the use of an adjusted CRT method named CRT-Advance focusing even more on advancement of the sleep-wake cycle can induce an antidepressant effect in selected patients that have drifted in their sleep during their depressive episode (enriched sample) (Aggestrup et al., 2023).

The Advance method acknowledges the importance of clinical contact between project staff and patients. In addition, patients will be asked to wear activity watches that measures light exposure and sleep/wake timing. Tracking participants individual behavior by accelerometers helps to reveal the invisible timing of the circadian system.

If the CRT-Advance method is effective, it can be established on a wider scale in psychoeducation manuals and guidelines for depression and the method can have a potential for psychiatric services making their treatment more cost-effective. An important point is that traditional treatment methods such as pharmacotherapy and psychotherapy is less effective in the presence of significant sleep problems due to daytime sleepiness and the depressiogenic effect of mistimed sleep.

On a societal scale, there is a large need for treatments for insomnia, and we also expect the CRT-Advance method to improve insomnia by reducing sleep onset problems through the advancement of sleep timing. This could reduce the use of dependence inducing hypnotics.

The number of non-pharmacological treatment methods are now growing as psychotropic drugs often are often associated with severe side effects and often a lack of efficacy. Therefore, there is a need for the testing of novel treatment methods based on existing theoretical background (Martiny, 2017).

Chronotherapy has provided evidence based new treatment options like light therapy, wake therapy, sleep time stabilization, and lately dark therapy (Henriksen et al., 2020, Gottlieb et al., 2019). The chronotherapeutic research field consists of a growing number of international research groups and societies, largely interdisciplinary, with basic researchers and clinicians around the world.

We also see a steady growth in the interest of chronotherapeutic application in Denmark (https://psy.au.dk/en/circadianpsychology).

With several new professorships in the field, this proposed project is highly likely to inspire the field further, making it easier to attract funding for research positions and international collaboration.

Methods The design is a randomised clinical trial (RCT), where participants with major depression and delayed sleep timing will be randomised into either a treatment as usual (TAU) group or a CRT-Advance group using psychoeducation methods to reset sleep timing to earlier. The CRT-Advance method is based on the use of (1) sleep diaries, (2) zeitgebers diaries diaries capturing time signals to the circadian system e.g. daylight, social contact, meals, and exercise), (3) close clinical weekly contact with focus on the result on sleep and mood of the psychoeducative method.

Actigraphy is recorded with the MotionWatch 8 (MW8, Camntech, UK), which provides an objective measure of sleep timing, 24-hour activity, night-sleep duration, night awakenings, sleep efficiency, day-time napping, and light exposure. Its algorithms on sleep have been validated against polysomnography (Wulff et al., 2006).

The MW8 is a wristwatch-like device that monitors activity levels and light levels for continuous periods, using accelerometer and light sensing technology. Specialised software (MotionWare Software) analyses data on sleep and circadian activity. Data can be directly downloaded from the watch using a simple USB cable. The MotionWatch 8 will be handed over at inclusion with detailed instructions. During the recording period, the participants will be encouraged to wear the watch continuously day and night. Patients are informed to use the marker button on the device to indicate when they intent to go to sleep (puts away book/phone/etc. and turns off lights). The investigator will download data at each study visit.

Psychoeducation material will be provided individually as part of the weekly clinical contact.

Patients will be followed weekly for eight weeks, thus each patient will receive nine sessions during the project - first visit on day 0, here after one visit every week for eight weeks. The patients must show up at the outpatient treatment unit for the sessions at day 0, week 2, week 4, week 6 and week 8 (final visit). The sessions at week 1, week 3, week 5 and week 7 will be offered as physical meetings as well but can be done over the phone if this is better for the patient.

The primary outcome is change in Hamilton Depression rating scale (HAM-D17) scores from baseline to endpoint (interview), (Licht et al., 2005).

Secondary outcomes are changes in sleep-midpoint, sleep onset and wake-up time from baseline to endpoint from the sleep diaries and based on activity tracking with the MotionWatch 8.

Exploratory outcomes are scores change from baseline to endpoint on the following questionnaires: Hamilton Depression rating scale (HAM-D6, self-rating version) (Bech et al., 2009), Pittsburgh Sleep Quality Index (PSQI, self-rating),(Buysse et al., 1989), WHO Five Well Being Index (WHO-5, self-rating), (Topp et al., 2015), Insomnia Severity Index (ISI, self-rating), (Bastien et al., 2001) Dysfunctional Believes and Attitudes about Sleep (DBAS, self-rating), (Espie et al., 2000), Epworth Sleepiness Scale (ESS, self-rating) and Morningness-Eveningness Questionnaire (MEQ, self-rating), (Horne and Ostberg, 1976). Furthermore, we will describe light exposure in the two groups. The sensors will be able to discern when patients are in daylight. We will also describe results from the sleep diaries and the chrono-schedule.

All patients will use the Motion Watch 8 for implementing and validating changes of sleep timing [34]. Adverse events will be monitored. The project will follow GCP regulations and will be approved by the Ethical Committees and the Danish Data Protection Agency.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
150 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Advance Project - Advancing Sleep Timing to Improve Depression, a Randomised Clinical Trial.
Anticipated Study Start Date :
Nov 1, 2023
Anticipated Primary Completion Date :
Apr 1, 2026
Anticipated Study Completion Date :
Jul 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Advance-group

The group will recieve 8 hours of psychotherapy with focus on advancing sleep timing, besides their treatment as usual.

Behavioral: CRT-Advance
Psychotherapy with focus on advancing sleep timing, using diaries on sleep and zeitgebers.

Active Comparator: Control-group

Treatment as usual at the outpaitent unit.

Behavioral: Treatment as usual
Treatment as usual in the outpatient psychiatric unit.

Outcome Measures

Primary Outcome Measures

  1. Hamilton D17 rating scale for depression [at inclusion and at endpoint (after eight weeks)]

    Hamilton D17 rating by blinded rater

Secondary Outcome Measures

  1. Changes in sleep-midpoint, sleep onset and sleep wake-up. [At inclusion and at endpoint (after eight weeks)]

    Measured both with sleep diaries and with actigraphy

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Moderate to major depression (DSM-V)

  • Discharge from psychiatric ward within last 30 days

  • Sleep onset and/or sleep off-set delayed minimum 1 hour based on the last three days, comparred to sleep in the last week of admittance at the psychiatric ward.

Exclusion Criteria:
  • Psychotic depression.

  • Cognitive problems making participation difficult.

  • Substance abuse (e.g. alcohol).

  • Increased suicidal risk.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mental Health Center Copenhagen Copenhagen Frederiksberg Denmark 2000

Sponsors and Collaborators

  • Mental Health Centre Copenhagen

Investigators

  • Study Director: Klaus Martiny, Professor, Mental Health Center Copenhagen

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Klaus Martiny, Professor, Mental Health Centre Copenhagen
ClinicalTrials.gov Identifier:
NCT06097221
Other Study ID Numbers:
  • ADVANCE
First Posted:
Oct 24, 2023
Last Update Posted:
Oct 24, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 24, 2023